Tusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine (SAR408701), which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab and DM4 (a potent maytansine derivative).
Purity:
98.5%
CAS Number:
[2349294-95-5]
* VAT and and shipping costs not included. Errors and price changes excepted
